Sterneck Capital Management, LLC Bristol Myers Squibb CO Transaction History

Sterneck Capital Management, LLC

$179 Million
Q3 2024

A detailed history of Sterneck Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sterneck Capital Management, LLC holds 6,062 shares of BMY stock, worth $327,105. This represents 0.17% of its overall portfolio holdings.

Number of Shares

6,062

Previous 6,062 -0.0%

Holding current value

$327,105

Previous $251,000 24.7%

% of portfolio

0.17%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$40.25 - $52.99 $12,276 - $16,161	305 Added 5.3%	6,062 $251,000
Q4 2023 Jan 12, 2024	BUY	$48.48 - $57.85 $43,632 - $52,065	900 Added 18.53%	5,757 $295,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $23,156 - $25,892	-400 Reduced 7.61%	4,857 $281,000
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $29,265 - $32,231	403 Added 8.3%	5,257 $405,000
Q1 2022 May 03, 2022	SELL	$61.48 - $73.72 $116,996 - $140,289	-1,903 Reduced 28.16%	4,854 $354,000
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $79,372 - $92,529	1,480 Added 28.05%	6,757 $421,000
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $107,748 - $126,213	1,821 Added 52.69%	5,277 $312,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $205,079 - $230,653	3,456 New	3,456 $218,000
Q4 2020 Jan 26, 2021	SELL	$57.74 - $65.43 $205,669 - $233,061	-3,562 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $57,430 - $63,640	-1,000 Reduced 21.92%	3,562 $215,000
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $87,712 - $102,544	-1,600 Reduced 25.97%	4,562 $268,000
Q4 2019 Feb 18, 2020	BUY	$49.21 - $64.19 $3,444 - $4,493	70 Added 1.15%	6,162 $396,000
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $17,108 - $20,284	-400 Reduced 6.16%	6,092 $309,000
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $35,696 - $39,472	800 Added 14.05%	6,492 $294,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $63,168 - $75,320	1,400 Added 32.62%	5,692 $272,000
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $82,785 - $93,375	-1,500 Reduced 25.9%	4,292 $266,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $50,530 - $62,980	1,000 Added 20.87%	5,792 $321,000
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $59,920 - $68,980	-1,000 Reduced 17.27%	4,792 $303,000
Q4 2017 Feb 07, 2018	SELL	$59.94 - $65.35 $143,076 - $155,990	-2,387 Reduced 29.18%	5,792 $355,000
Q2 2017 Aug 16, 2017	BUY	N/A	8,179	8,179 $456,000

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterneck Capital Management, LLC with notifications on news.

Account

Sterneck Capital Management, LLC Bristol Myers Squibb CO Transaction History